Teva Pharmaceutical Industries (TEVA) Capital Expenditures (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) posted Capital Expenditures of $104 million for Q2 2026, up 8.3% from $96 million a year earlier but down 38.1% from the prior quarter.
Teva Pharmaceutical Industries (TEVA) Capital Expenditures (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Teva Pharmaceutical Industries was $550 million, up 10.0% year-over-year; for FY2025, it came in at $501 million, up 0.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -2.8% (FY2020 to FY2025).
- In prior years, Teva Pharmaceutical Industries' Capital Expenditures was $498 million in FY2024 (-5.3%), $526 million in FY2023 (-4.0%), $548 million in FY2022 (-2.5%) and $562 million in FY2021 (-2.8%).
- Quarterly Capital Expenditures has run from a low of $96 million in Q2 2025 to a high of $168 million in Q1 2026 over five years.
- On a year-over-year basis, Capital Expenditures has increased in each of the last three quarters, with growth averaging 6.5% over the last eight quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2026, with growth of 32.3%; the weakest was Q2 2024, with a decline of 18.5%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $168 million (Q1 2026), $142 million (Q4 2025) and $136 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn | 104.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.00 Mn |
| Mar 31, 2026 | 168.00 Mn |
| Dec 31, 2025 | 142.00 Mn |
| Sep 30, 2025 | 136.00 Mn |
| Jun 30, 2025 | 96.00 Mn |
| Mar 31, 2025 | 127.00 Mn |
| Dec 31, 2024 | 129.00 Mn |
| Sep 30, 2024 | 148.00 Mn |
| Jun 30, 2024 | 97.00 Mn |
| Mar 31, 2024 | 124.00 Mn |
| Dec 31, 2023 | 119.00 Mn |
| Sep 30, 2023 | 149.00 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Mar 31, 2023 | 139.00 Mn |
| Dec 31, 2022 | 142.00 Mn |
| Sep 30, 2022 | 122.00 Mn |
| Jun 30, 2022 | 127.00 Mn |
| Mar 31, 2022 | 157.00 Mn |
| Dec 31, 2021 | 153.00 Mn |
| Sep 30, 2021 | 146.00 Mn |
Teva Pharmaceutical Industries Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TEVA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();